Daniel Landi
Showing 1 - 25 of 29
Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three
Recruiting
- Malignant Glioma
- D2C7-IT (6920 ng/mL via convection-enhanced delivery)
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 22, 2022
Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)
Not yet recruiting
- Advanced Solid Tumor
- +2 more
-
Palo Alto, California
- +9 more
Aug 2, 2022
Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)
Recruiting
- Recurrent Medulloblastoma
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jan 8, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,
Not yet recruiting
- High Grade Glioma
- +2 more
- PEP-CMV
- +2 more
-
Aurora, Colorado
- +9 more
Jan 28, 2022
Frailty, Disability Physical, Old Age; Atrophy Trial (EDUcation, EXERcise, EDU-EXER)
Not yet recruiting
- Frailty
- +2 more
- EDUcation
- +3 more
- (no location specified)
Mar 6, 2023
Long-term Sequelae of COVID-19: An International Cross-Sectional
Recruiting
- Myalgic Encephalomyelitis
- This is an observational cross-sectional study, there is no need for intervention
-
Alexandria, EgyptAlexandria Faculty of Medicine
Sep 25, 2021
Spasticity as Sequela of Stroke Trial in Madrid (Dry needling + usual care, Sham dry needling + usual care)
Not yet recruiting
- Spasticity as Sequela of Stroke
- Dry needling + usual care
- Sham dry needling + usual care
-
Madrid, SpainCentro Europeo de Neurociencias
Aug 24, 2023
COVID-19 Trial in Edison (Omega-3 (EPA+DHA), Placebo)
Recruiting
- COVID-19
- Omega-3 (EPA+DHA)
- Placebo
-
Edison, New JerseyHackensack Meridian Health
Dec 13, 2022
COVID-19 Vaccination Status and The Clinical Outcomes of Long
Recruiting
- COVID-19
- SARS CoV-2 Infection
- COVID-19 Vaccine
-
Jakarta Pusat, DKI Jakarta, IndonesiaRespirology and Critical Care Medicine Division, Departement of
Oct 26, 2022
PET Scanning in Parkinson s Disease
Recruiting
- Schizophrenia
- Parkinson's Disease
- 18F-Fluoro-L-dopa
- O-15 Water
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Post-COVID-19 Condition, Post-COVID-19 Syndrome, Cognitive Impairment Trial in Toronto (Vortioxetine, Placebo)
Recruiting
- Post-COVID-19 Condition
- +2 more
- Vortioxetine
- Placebo
-
Toronto, Ontario, CanadaBrain and Cognition Discovery Foundation (BCDF)
Jul 19, 2022
Colonic Adenocarcinoma Trial in France (LV5FU2 or capectitabine, FOLFOX4 or XELOX, Observation)
Recruiting
- Colonic Adenocarcinoma
- LV5FU2 or capectitabine
- +3 more
-
Fort De France, Guadeloupe, France
- +139 more
Mar 23, 2022
Metastatic Pancreatic Cancer Trial in France, Martinique (Irinotecan Liposomal Injection, 5-FU/LV, Nab-Paclitaxel)
Recruiting
- Metastatic Pancreatic Cancer
- Irinotecan Liposomal Injection
- +3 more
-
Amiens, France
- +35 more
Mar 23, 2022
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)
Recruiting
- Gastrointestinal Stromal Tumors
- +4 more
- Imatinib maintenance
-
Marseille, Bouches Du Rhône, France
- +16 more
Jul 28, 2021
Understanding of Community Immunity as a Concept Trial (herdimm, guardianmeasles, theotheredmundmeasles)
Not yet recruiting
- Understanding of Community Immunity as a Concept
- herdimm
- +5 more
- (no location specified)
Mar 4, 2021
Schizophrenia, Psychotic Disorders Trial in Belgium, Netherlands (olanzapine, ziprasidone)
Completed
- Schizophrenia
- Psychotic Disorders
-
Antwerpen, Belgium
- +6 more
Feb 18, 2021
Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency Trial in Worldwide (Carillon Mitral Contour System,
Recruiting
- Functional Mitral Regurgitation
- +5 more
- Carillon Mitral Contour System
- Guideline Directed Heart Failure Medication
-
Gilbert, Arizona
- +47 more
Oct 10, 2021
Glioblastoma, Gliosarcoma Trial in Durham (EGFRvIII CAR T cells)
Terminated
- Glioblastoma
- Gliosarcoma
- EGFRvIII CAR T cells
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Jul 8, 2020
Fernald Community Cohort -18 Year Observational Study
Active, not recruiting
- Cancer
- +3 more
-
Cincinnati, OhioUniversity of Cincinnati
Mar 1, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Blue Protocol Assessment
Unknown status
- Dyspnea
- Emergencies
- lung ultrasound
-
Amiens, FranceCHU Amiens
Jan 7, 2020
Renal Ageing-sarcopenia Network
Unknown status
- Aging
- +3 more
-
Milan, ItalyIRCCS Ospedale San Raffaele
Dec 9, 2020
Do Your Genes Put You atHigher Risk of Developing Mesothelioma
Completed
- Mesothelioma
-
Baltimore, Maryland
- +5 more
Nov 3, 2017